CDKN1A and colorectal carcinoma: This leads to inhibition of the AKT/ERK signaling pathway and upregulation of p21, WAF1/Cip1, Chk1, and Chk2, which contribute to CRC tumorigenesis (Donohoe et al., 2014; Li Q. et al., 2017).